cipro 750mg
The phase 1/2 trial of the REGEN-COV (casirivimab and imdevimab) antibody cocktail from Regeneron conducted on 799 individuals shows that
Read moreThe phase 1/2 trial of the REGEN-COV (casirivimab and imdevimab) antibody cocktail from Regeneron conducted on 799 individuals shows that
Read moreAn experimental, lab-made antibody can completely prevent nonhuman primates from being infected with the monkey form of HIV, new research
Read moreNew research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe
Read moreResearchers in the United States have provided the first evidence that messenger RNA (mRNA)-based vaccines against severe acute respiratory coronavirus
Read moreNew research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe
Read moreThe coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally. To
Read moreUS biotech firm Regeneron and its Swiss partner Roche unveiled promising clinical trial results Monday indicating that an antibody treatment
Read morePregnant women are at high risk for severe COVID-19 infection and death. Yet, insufficient safety data on babies has led
Read moreinsights from industrySanti Dominguez & Michael GrazCEO & Acting CEOImspex Diagnostics & Imspex Medical In this interview, News-Medical talks to
Read moreNew findings from a Michigan Medicine study reveal that antibody testing is predictive of prior COVID-19 infection, and rapid screening
Read more